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Received March 30, 2013; accepted June 10, 2013AbstractBackground: Anterior cervical discectomy and fusion is one of the most common surgical interventions performed by spine surgeons. As efforts
are made to control healthcare spending because of the limited or capped resources offered by the National Health Insurance, surgeons are faced
with the challenge of offering high-level patient care while minimizing associated healthcare expenditures. Routine ordering of postoperative
hematologic tests and observational intensive care unit (ICU) stay might be areas of potential cost containment. This study was designed to
determine the necessity of routine postoperative hematologic tests and ICU stay for patients undergoing elective anterior cervical discectomy and
fusion and to investigate whether the elimination of unnecessary postoperative laboratory blood studies and ICU stay inhibits patient care.
Methods: The necessity for postoperative blood tests was determined if there were needs for a postoperative blood transfusion and hospital
readmission within 1 month after surgery. The necessity for postoperative ICU observation was decided if immediate surgical intervention was
required when any kind of complications occurred during the ICU stay.
Results: There were 168 patients collected in the study. Among them, all had routine preoperative and postoperative blood tests and were
transferred to ICU for observation. No need for blood transfusion was observed, and no patient required immediate surgical intervention when
the complications occurred during the ICU stay.
Conclusion: Cost savings per admission amounted to approximately 10% of the hospitalization cost by the elimination of unnecessary post-
operative routine laboratory blood studies and observational ICU stay without waiving patient care in the current volatile, cost-conscious
healthcare environment in Taiwan.
Copyright  2013 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved.
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increasing number of ACDF procedures performed annually is
believed to be attributed to the decreased length of hospital
stays, decreases in complications, the provision of symptom
relief and, more importantly, the improvement of quality of
life.3,5 As efforts are made to control healthcare spending
because of the limited or capped resources offered by the
National Health Insurance (NHI), surgeons are faced with the
challenge of offering high-level patient care while minimizing
associated healthcare expenditures.3,4hinese Medical Association. All rights reserved.
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tried to change ACDF from a principally inpatient to an
outpatient procedure.6e10 However, the extensive adoption of
this procedure as a standard of care has not occurred because
different risksdcomplications such as intraoperative vascular
injury, postoperative dysphagia, soft-tissue swelling, wound
hematoma, esophageal or pharyngeal perforation, hardware
failure, and nerve damagedmust be taken into consid-
eration.11e14 Therefore, at most hospitals, ACDF remains an
inpatient procedure with an average stay of 2e8 days.4,5
Routine ordering of postoperative hematologic tests3 and
postoperative observational stay in the intensive care unit
(ICU) might be areas of potential cost containment. Vital
signs, physical examination, and these blood studies are key
determinants for surgeons deciding whether a patient needs a
blood transfusion. Routine transfer of a patient into ICU after
ACDF is also a part of a standardized postoperative order set
at our neuroscience center to ensure prompt intervention is
offered if complications occur. However, these blood tests and
observational stay in the ICU have only become parts of a
standardized postoperative order set and are ordered without
regard for necessity or specific patient- or surgery-related
factors.Fig. 1. Patient selIn this study, the focus was to determine the necessity of
routine postoperative hematologic tests and observational stay
in the ICU for patients undergoing ACDF for DCS, i.e., to
investigate whether the elimination of unnecessary post-
operative laboratory blood studies and ICU stay for observa-
tion inhibits patient care.
2. Methods
After Institutional Review Board approval was obtained,
the authors reviewed retrospectively the patient database of the
Neuroscience Center of Kaohsiung Medical University Hos-
pital and identified 266 consecutive patients with DCS who
underwent ACDF for single- to multi-level diseases by neu-
rosurgeons from January 2009 to December 2011 at their
medical center (Fig. 1). Polyetheretherketone intervertebral
cages and Bryan discs were used as fusion material. Patients
were excluded based on C1-2 involvement, trauma, neoplasia,
or previous cervical fusion/operation.
By reviewing the complete medical records, which con-
sisted of operative notes, discharge notes, laboratory data,
demographic and clinical datadincluding patient age, sex,
number of levels involved, complications, pre- andection chart.
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tion, complete blood count, coagulation studies, and type),
estimated blood loss, postoperative transfusion, length of
hospital stay, length of ICU stay, hospitalization cost, and
incidence of hospital readmissions within 1 month after sur-
gery for complicationsdwere collected. Cost data were esti-
mated by using hospital inpatient reimbursement (NHI) data.
Data were analyzed using Student t test, one-way analysis of
variance or Pearson c2 test as appropriate. The necessity for
postoperative blood tests was determined if there was need for
a postoperative blood transfusion and/or hospital readmission
within 1 month after surgery. The necessity for postoperative
ICU observation was decided if immediate surgical interven-
tion was required when any kind of complications occurred
during the ICU stay. A p value of <0.05 was considered sta-
tistically significant. Statistical analyses for the study were
performed using SPSS version 12.0 for Windows (SPSS Inc.,
Chicago, IL, USA).3. Results
Of 266 patients screened, 168 (80 men and 88 women) met
the inclusion criteria. All patients had one preoperative test of
biochemistry, complete blood count, coagulation, and type and
one postoperative test of biochemistry and complete blood
count. All patients were planned to be transferred to ICU for
postoperative observation. Table 1 shows that their average
age was 54.89 years (range, 21e85 years), average estimated
blood loss was 63.27 mL (median, 30 mL; range, 5e355 mL),
average length of hospital stay was 8.55 days (range, 4e39
days), average length of ICU stay was 1.20 days (range, 0e3
days), and the average hospitalization cost was
US$3325.43  901.64 (range, US$747.93e5965.38; currencyTable 1
Patient demographics (n ¼ 168).
Age, y 54.89  12.30 (21e85)
Sex, F/M (%) 88 (52.4)/80 (47.6)
BMI 24.51  4.03 (15.40e38.72)
CCI
0 78 (46.4)
1 90 (53.6)
ASA status
II 142 (84.5)
III 26 (15.5)
Level of ACDF
1-level 37 (22.0)
2-level 73 (43.5)
Multi-levela 58 (34.5)
Estimated blood loss, mL 63.27  74.34 (5e355)
Complication 41 (24.4)
Length of hospital stay, d 8.55  4.41 (4e39)
Length of ICU stay, d 1.20  0.50 (0e3)
Hospitalization cost, US$ 3325.43  901.64 (747.93e5965.38)
Data are presented as n (%) or mean  SD (range).
ACDF ¼ Anterior cervical discectomy and fusion; ASA ¼ American Society
of Anesthesiologists BMI ¼ body mass index; CCI ¼ Charlson comorbidity
index; ICU ¼ intensive care unit.
a Multilevel ¼ three levels.exchange of US$ to NT$ is 1/30.12). Postoperative compli-
cations occurred in 24.4% of the patients (Tables 1 and 2).
They were generally mild postoperative nausea, vomiting, and
dizziness without the need for intensive care. Furthermore, no
complication required immediate surgical intervention. There
were no hematomas, airway complications, or deaths.
The study population was further divided into three groups:
those who underwent one-level ACDF; those who underwent
two-level ACDF; and those who underwent 3-level (multi-
level) ACDF. No significant differences were found between
groups in terms of sex, length of hospital stay, or length of ICU
stay (Table 3). Patients undergoing multi-level ACDF were
significantly older than those who underwent two-level and
one-level ACDF ( p ¼ 0.01 and p < 0.001, respectively). In
addition, the multi-level group had significantly greater esti-
mated blood loss (comparing multi-level vs. two- and one-
level, p ¼ 0.02 and p ¼ 0.01, respectively). Incidence of
complications was significantly associated with levels of the
disease ( p ¼ 0.02). No subsequent need for blood tests or
transfusion was observed when the complications occurred in
the study population. No patient required immediate surgical
intervention when the complications occurred during the ICU
stay. In addition, no patient required hospital readmission
within 1 month after surgery for complications.
4. Discussion
Effort to reduce medical costs is always demanded as
healthcare reform continues to change the landscape of single-
payer medical reimbursement system here in Taiwan. All in
all, a balance between such decreases in healthcare costs and
the quality of patient care must be found. Because most
medical care costs in ACDF are derived from the implants
used and these costs are typically fixed, the potential decreases
in costs will only be found in changes to the pre- and post-
surgical aspects of routine patient care.
Laboratory blood tests after surgical interventions are
routine and common. However, these studies frequently
become part of a postoperative care protocol with little regard
for patient-specific or surgery-related characteristics. In addi-
tion, the necessity of the studies for all surgical cases has never
been proven.3 Acute postoperative anemia is one of the most
common reasons for postoperative blood tests, e.g., complete
blood count. However, postoperative anemia has never been
previously reported as a common complication in ACDF. InTable 2
Complications and their relevance.
Complications 41 (24.4) Related
Agitation 3 (1.8) Anesthesia
PONV 17 (10.1) Anesthesia
Mild sore throat 18 (10.7) Anesthesia
Mild dizziness 3 (1.8) Anesthesia
Wound hematoma 0 Surgery
Airway compression 0 Surgery
Data are presented as n (%).
PONV ¼ postoperative nausea and vomiting.
Table 3
Comparison by levels of anterior cervical discectomy and fusion.
1 level (n ¼ 37) 2 levels (n ¼ 73) Multilevel (n ¼ 58) p
Age, y 50.41  14.27 53.79  11.12 59.60  10.70 <0.001
No. female 23 (62.2) 38 (52.1) 27 (45.6) 0.36a
Complication 15 (36.6) 17 (41.5) 9 (22.0) 0.02a
Estimated blood loss, mL 30.95  28.18 59.52  73.72 94.47  118.54 <0.001
Length of hospital stay, d 7.65  3.97 8.53  5.03 9.18  3.79 0.26
Length of ICU stay, d 1.24  0.55 1.16  0.47 1.23  0.50 0.66
Data are presented as n (%) or mean  SD.
ICU ¼ intensive care unit; LSD ¼ Fisher’s least significant difference.
a Number of female patients and complications between all groups were tested by c2 test, others were compared by one-way analysis of variance. (Post hoc test:
LSD).
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because intraoperative blood loss was scant. The overall
average estimated intraoperative blood loss was 63.27 mL
(range, 5e355 mL) with a median of 30 mL. Significantly
older age and greater estimated blood loss were found in pa-
tients undergoing multi-level ACDF procedures when
compared with both two-level and one-level procedures. These
findings are not surprising because of the age-related patho-
genesis and the increased complexity of the multilevel cases.
However, the average estimated blood loss was still < 100 mL
in patients undergoing multilevel ACDF procedures. The true
value of postoperative blood tests seems then limited to the
early identification of postoperative anemia that they offer,
which allows for prime resuscitation, reduces the risk for
secondary complications, and helps to speed healing and
overall recovery. Obviously, the necessity of postoperative
routine blood tests should be evaluated prudently.
Common complications associated with ACDF include
intraoperative vascular injury, postoperative dysphagia, soft-
tissue swelling, wound hematoma, esophageal or pharyngeal
perforation, recurrent laryngeal nerve palsy, worsening
myelopathy, hardware failure, and nerve damage.11e14
Delayed bleeding is a rare complication of ACDF, which is
found at least 9 days after surgery and after patients are dis-
charged.15 Postoperative blood studies would not be likely to
reveal these vascular complications in the acute postoperative
setting. Postoperative observational stay in the ICU would not
reveal these vascular complications in the acute postoperative
setting, either. However, surgeons must always be cautious of
possible vascular injury and therefore monitor vital signs in
addition to patient-specific objectives on the general wards.
The findings in this study are broadly consistent with those
of previously published studies in other fields of medicine
focusing on the necessity of routine postoperative blood tests,
which recommend that postoperative blood tests should be
limited to those patients who have had previous hematologic
issues, baseline anemia or identifiable risk factors and those
with excessive intraoperative blood loss.16,17 Postoperative
blood studies are also suggested to be streamlined to those
measurements that might lead to therapeutic intervention.18
Our findings lend support to the suggestion that no post-
operative blood test is to be routinely performed for patients
undergoing ACDF procedures unless they have had a comor-
bidity of DM, coagulation disorders, and severe hepatic and/orrenal dysfunctions. However, studies related to the limitation
of ICU use are lacking. Whether or not to routinely transfer a
patient into ICU for observation after ACDF procedure is still
controversial; some centers such as our neuroscience center
do, but some do not. Our findings suggest that postoperative
observational ICU stay is required for patients undergoing
multilevel ACDF procedures for the improvement of cost
savings. Further studies examining potential complications
with the levels of disease should target patients in specific
conditions.
According to the reimbursement guidelines provided by the
Bureau of NHI, the average cost of routine biochemical tests
(for liver and kidney function) is US$4.32, the cost of routine
biochemical tests plus complete blood count is US$6.64, the
cost of a coagulation panel is US$4.98, the cost of a typing is
US$1, and the cost for ICU stay/day is US$239.04 at the au-
thors’ institution. These costs are universally reimbursed to
every medical center nationwide. The average length of hos-
pital stay and ICU stay of the present study were 8.55 days and
1.20 days, respectively. However, no differences in the average
length of hospital stay and ICU stay were found between
groups, indicating these two parameters were not strongly
impacted by the severity of the disease. On the basis of the
authors’ data, the costs for blood tests/admission totaled
US$19.26/patient, which included US$6.64 for postoperative
blood tests. No blood transfusion or any therapeutic inter-
vention during ICU and hospital stay was noted in the study
population, implying feasibility of saving the cost for post-
operative observation in the ICU and hematologic laboratory
studies, no matter the severity of the disease. Postoperative
observation in the ICU and hematologic laboratory studies
were thus decided to be “unnecessary” and their costs were
eliminated as well. From the viewpoint of hospitalization, 1.2
days (average ICU stay) could be saved, indicating 14% of
hospital stay is generally preserved. ICU admission is
frequently denied because beds are not readily available and
its provision of focused and aggressive medical intervention to
critically ill patients is sometimes unplanned. It may be more
effective to reserve these ICU beds for critically ill patients
rather than for patients undergoing elective ACDF. Cost sav-
ings per admission by subtracting unnecessary postoperative
management of laboratory blood studies and observational
ICU stays amounted to US$293.49/patient, i.e., approximately
10% of the hospitalization cost. If extrapolated to include the
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around 1500 patients, the total cost savings would be
US$440,232/year. Adjustment to the national data of the
average length of both hospital and ICU stay should be done to
describe precisely the national cost savings for patients
receiving ACDF procedures.
Limitations of this study include a lack of prospective
randomized design, the small sample size, limited cost-saving
analyses, and limited sources obtained from a single depart-
ment (neurosurgery) at our institution. A large, prospective
randomized study is warranted to delineate further the ne-
cessity of postoperative hematologic laboratory studies and
observation in the ICU in all patients undergoing ACDF.
Studies on other neurosurgical procedures, such as posterior
cervical surgery and lumbar spine decompression, are also
warranted. Full cost-saving analyses would include the inter-
pretation of direct and indirect costs, e.g., implant choice,
anesthesia cost, operative time, hospital stay, impact of com-
plications, and return to work. However, such analyses were
outside the scope of this study. In addition, the current study
focused on the need for immediate postoperative hematologic
laboratory studies and observation in the ICU in a specific
patient population: those who were without any intraoperative
complications or previous history of hematologic issues. The
generalizability or applicability of the study conclusions is
therefore limited.
In conclusion, the present study exemplifies the authors’
intention to assess definitively the necessity of postoperative
hematologic laboratory studies and observation in the ICU in
patients undergoing elective ACDF because these procedures
are associated with low intraoperative blood loss and shorter
hospital stays. It will be more effective to reserve these ICU
beds for critically ill patients rather than for patients following
elective ACDF. The elimination of unnecessary postoperative
laboratory blood studies and ICU stay for observation for
patients undergoing elective ACDF is a definite and feasible
way to improve cost savings without waiving patient care in
the current volatile, cost-conscious healthcare environment in
Taiwan. The patient-specific objective and subjective mea-
sures and monitoring of vital signs on the general wards can
still play key roles in sustaining patient care. By this approach,
the cumulative savings to the healthcare system might be
perceptible.
Acknowledgments
Dr. Ching-Kuo Lin and Chih-Lung Lin contributed equally
to this study. The study was approved by the Institutional
Review Board of Kaohsiung Medical University Hospital
(KMUH-IRB-990271). The authors would like to thankRichard H. Davis, M.A., English teacher, for proofreading the
English grammar and editing.References
1. Patil PG, Turner DA, Pietrobon R. National trends in surgical procedures
for degenerative cervical spine disease: 1990e2000. Neurosurgery
2005;57:753e8.
2. Cowan Jr JA, Dimick JB, Wainess R, Upchurch Jr GR, Chandler WF, La
Marca F. Changes in the utilization of spinal fusion in the United States.
Neurosurgery 2006;59:15e20.
3. Tan EW, Jain A, Hassanzadeh H, Bernard JA, Lemma MA. Role of he-
matologic laboratory studies in the postoperative management of patients
undergoing anterior cervical discectomy and fusion. Orthopedics
2012;35:e917e21.
4. Feng YT, Hwang SL, Lin CL, Lee IC, Lee KT. Safety and resource uti-
lization of anterior cervical discectomy and fusion. Kaohsiung J Med Sci
2012;28:495e9.
5. Marawar S, Girardi FP, Sama AA, Ma Y, Gaber-Baylis LK,
Besculides MC, et al. National trends in anterior cervical fusion pro-
cedures. Spine 2010;35:1454e9.
6. Castro Jr FP, Holt RT, Majd M, Whitecloud 3rd TS. A cost analysis of two
anterior cervical fusion procedures. J Spinal Disord 2000;13:511e4.
7. Silvers HR, Lewis PJ, Suddaby LS, Asch HL, Clabeaux DE,
Blumenson LE. Day surgery for cervical microdiscectomy: Is it safe and
effective? J Spinal Disord 1996;9:287e93.
8. Angevine PD, Zivin JG, McCormick PC. Cost-effectiveness of single-
level anterior cervical discectomy and fusion for cervical spondylosis.
Spine 2005;30:1989e97.
9. Erickson M, Fites BS, Thieken MT, McGee AW. Outpatient anterior
cervical discectomy and fusion. Am J Orthop 2007;36:429e32.
10. Garringer SM, Sasso RC. Safety of anterior cervical discectomy and
fusion performed as outpatient surgery. J Spinal Disord Tech
2010;23:439e43.
11. Burke JP, Gerszten PC, Welch WC. Iatrogenic vertebral artery injury
during anterior cervical spine surgery. Spine J 2005;5:508e14.
12. Kepler CK, Rihn JA, Bennett JD, Anderson DG, Vaccaro AR, Albert TJ,
et al. Dysphagia and soft-tissue swelling after anterior cervical surgery: a
radiographic analysis. Spine J 2012;12:639e44.
13. Campbell PG, Yadla S, Malone J, Zussman B, Maltenfort MG, Sharan AD,
et al. Early complications related to approach in cervical spine surgery:
single-center prospective study.World Neurosurg 2010;74:363e8.
14. Fountas KN, Kapsalaki EZ, Nikolakakos LG, Smisson HF, Johnston KW,
Grigorian AA, et al. Anterior cervical discectomy and fusion associated
complications. Spine 2007;32:2310e7.
15. Jenis LG, Leclair WJ. Late vascular complication with anterior cervical
discectomy and fusion. Spine 1994;19:1291e3.
16. Horowitz E, Yogev Y, Ben-Haroush A, Rabinerson D, Feldberg D,
Kaplan B. Routine hemoglobin testing following an elective Cesarean
section: is it necessary? J Matern Fetal Neonatal 2003;14:223e5.
17. Ransom SB, Fundaro G, Dombrowski MP. Cost-effectiveness of routine
blood type and screen testing for cesarean section. J Reprod Med
1999;44:592e4.
18. Skenderis 2nd BS, Rodriguez-Bigas M, Weber TK, Petrelli NJ. Utility of
routine postoperative laboratory studies in patients undergoing potentially
curative resection for adenocarcinoma of the colon and rectum. Cancer
Invest 1999;17:102e9.
